Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
Main Authors: | Masato Furuhashi, Shigeyuki Saitoh, Kazuaki Shimamoto, Tetsuji Miura |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-02-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | http://www.la-press.com/fatty-acid-binding-protein-4-fabp4-pathophysiological-insights-and-pot-article-a4641 |
Similar Items
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
by: Masato Furuhashi, et al.
Published: (2014-01-01) -
Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
by: Norie Saito, et al.
Published: (2021-02-01) -
Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
by: Yusuke Okazaki, et al.
Published: (2014-01-01) -
Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
by: Masato Furuhashi, et al.
Published: (2017-03-01) -
Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells.
by: Tokunori Yamamoto, et al.
Published: (2016-01-01)